Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis. 2019

Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
Department of Medical Sciences, University of Turin, Turin, Italy.

Human liver stem-like cells (HLSC) and derived extracellular vesicles (EVs) were previously shown to exhibit anti-tumor activity. In our study, we investigated whether HLSC-derived EVs (HLSC-EVs) were able to inhibit tumor angiogenesis in vitro and in vivo, in comparison with EVs derived from mesenchymal stem cells (MSC-EVs). The results obtained indicated that HLSC-EVs, but not MSC-EVs, inhibited the angiogenic properties of tumor-derived endothelial cells (TEC) both in vitro and in vivo in a model of subcutaneous implantation in Matrigel. Treatment of TEC with HLSC-EVs led to the down-regulation of pro-angiogenic genes. Since HLSC-EVs carry a specific set of microRNAs (miRNAs) that could target these genes, we investigated their potential role by transfecting TEC with HLSC-EV specific miRNAs. We observed that four miRNAs, namely miR-15a, miR-181b, miR-320c and miR-874, significantly inhibited the angiogenic properties of TEC in vitro, and decreased the expression of some predicted target genes (ITGB3, FGF1, EPHB4 and PLAU). In parallel, TEC treated with HLSC-EVs significantly enhanced expression of miR-15a, miR-181b, miR-320c and miR-874 associated with the down-regulation of FGF1 and PLAU. In summary, HLSC-EVs possess an anti-tumorigenic effect, based on their ability to inhibit tumor angiogenesis.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D009389 Neovascularization, Pathologic A pathologic process consisting of the proliferation of blood vessels in abnormal tissues or in abnormal positions. Angiogenesis, Pathologic,Angiogenesis, Pathological,Neovascularization, Pathological,Pathologic Angiogenesis,Pathologic Neovascularization,Pathological Angiogenesis,Pathological Neovascularization
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067128 Extracellular Vesicles Membrane limited structures derived from cell membranes and cytoplasmic material, and released into EXTRACELLULAR SPACE. They circulate through the EXTRACELLULAR FLUID and through the peripheral blood in the MICROVASCULATURE where cells, much larger, cannot, thereby affecting a variety of intercellular communication processes. Apoptotic Bodies,Exovesicles,Apoptotic Body,Bodies, Apoptotic,Body, Apoptotic,Exovesicle,Extracellular Vesicle,Vesicle, Extracellular,Vesicles, Extracellular
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013234 Stem Cells Relatively undifferentiated cells that retain the ability to divide and proliferate throughout postnatal life to provide progenitor cells that can differentiate into specialized cells. Colony-Forming Units,Mother Cells,Progenitor Cells,Colony-Forming Unit,Cell, Mother,Cell, Progenitor,Cell, Stem,Cells, Mother,Cells, Progenitor,Cells, Stem,Colony Forming Unit,Colony Forming Units,Mother Cell,Progenitor Cell,Stem Cell
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D022781 Hepatocytes The main structural component of the LIVER. They are specialized EPITHELIAL CELLS that are organized into interconnected plates called lobules. Hepatic Cells,Cell, Hepatic,Cells, Hepatic,Hepatic Cell,Hepatocyte
D023041 Xenograft Model Antitumor Assays In vivo methods of screening investigative anticancer drugs, biologic response modifiers or radiotherapies. Human tumor tissue or cells are transplanted into mice or rats followed by tumor treatment regimens. A variety of outcomes are monitored to assess antitumor effectiveness. Tumor Xenograft Assay,Xenograft Antitumor Assays,Antitumor Assays, Xenograft Model,Antitumor Assay, Xenograft,Antitumor Assays, Xenograft,Assay, Tumor Xenograft,Assay, Xenograft Antitumor,Assays, Tumor Xenograft,Assays, Xenograft Antitumor,Tumor Xenograft Assays,Xenograft Antitumor Assay,Xenograft Assay, Tumor,Xenograft Assays, Tumor

Related Publications

Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
September 2020, International journal of cancer,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
July 2017, Stem cell research & therapy,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
November 2002, Cancer research,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
June 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
June 2020, Plastic and reconstructive surgery,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
July 2020, Plastic and reconstructive surgery,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
October 2019, Plastic and reconstructive surgery,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
January 2021, Frontiers in medicine,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
January 2024, Expert opinion on therapeutic targets,
Tatiana Lopatina, and Cristina Grange, and Valentina Fonsato, and Marta Tapparo, and Alessia Brossa, and Sofia Fallo, and Adriana Pitino, and Maria Beatriz Herrera-Sanchez, and Sharad Kholia, and Giovanni Camussi, and Benedetta Bussolati
January 2017, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!